{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-309716","form_type":"8-K","ticker":"IDYA","cik":"0001676725","company_name":"IDEAYA Biosciences, Inc.","filed_at":"2025-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.122819+00:00","generated_at":"2026-05-16T14:16:24.382082+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"GSK terminates collaboration; IDEAYA regains IDE275 and IDE705; cash runway unchanged","bullets":["GSK terminates Collaboration, Option and License Agreement effective 90 days after Dec 4, 2025; programs transferred back to IDEAYA.","IDEAYA to evaluate strategic options for IDE275 (Werner Helicase) and IDE705 (Pol Theta) in 2026.","Company reaffirms cash runway into 2030, unchanged by the termination."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-309716","json":"https://secwatch.observer/filing/0001193125-25-309716.json","markdown":"https://secwatch.observer/filing/0001193125-25-309716.md","text":"https://secwatch.observer/filing/0001193125-25-309716.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676725/000119312525309716/0001193125-25-309716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676725/000119312525309716/d87387d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T14:16:24.382082+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}